NCT02623062View on ClinicalTrials.gov

Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study

PHASE3CompletedINTERVENTIONAL
Enrollment

644

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

May 31, 2016

Conditions
Gastro-esophageal Reflux Disease (GERD)
Interventions
DRUG

Compound Sodium Alginate Oral Suspension sachet

Contents of 2 sachets taken four times daily for 7 days

DRUG

Matched placebo

Contents of 2 sachets taken four times daily for 7 days

Trial Locations (1)

510080

The First Affilated Hospital Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Reckitt Benckiser Healthcare (UK) Limited

INDUSTRY

NCT02623062 - Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study | Biotech Hunter | Biotech Hunter